| COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus L Scarfò, T Chatzikonstantinou, GM Rigolin, G Quaresmini, M Motta, ... Leukemia 34 (9), 2354-2363, 2020 | 272 | 2020 |
| In CLL, comorbidities and the complex karyotype are associated with an inferior outcome independently of CLL-IPI GM Rigolin, M Cavallari, FM Quaglia, L Formigaro, E Lista, A Urso, ... Blood, The Journal of the American Society of Hematology 129 (26), 3495-3498, 2017 | 103 | 2017 |
| EBV DNA increase in COVID-19 patients with impaired lymphocyte subpopulation count S Paolucci, I Cassaniti, F Novazzi, L Fiorina, A Piralla, G Comolli, R Bruno, ... International Journal of Infectious Diseases 104, 315-319, 2021 | 95 | 2021 |
| COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study T Chatzikonstantinou, A Kapetanakis, L Scarfò, G Karakatsoulis, D Allsup, ... Leukemia 35 (12), 3444-3454, 2021 | 88 | 2021 |
| Lack of SARS-CoV-2 RNA environmental contamination in a tertiary referral hospital for infectious diseases in Northern Italy M Colaneri, E Seminari, A Piralla, V Zuccaro, A Di Filippo, F Baldanti, ... Journal of Hospital Infection 105 (3), 474-476, 2020 | 83 | 2020 |
| Outcomes in first relapsed-refractory younger patients with mantle cell lymphoma: results from the MANTLE-FIRST study C Visco, A Di Rocco, A Evangelista, FM Quaglia, MC Tisi, L Morello, ... Leukemia 35 (3), 787-795, 2021 | 77 | 2021 |
| Efficacy of R‐BAC in relapsed, refractory mantle cell lymphoma post BTK inhibitor therapy R McCulloch, C Visco, TA Eyre, R Frewin, N Phillips, DL Tucker, ... British journal of haematology 189 (4), 684-688, 2020 | 68 | 2020 |
| Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: clinical and biological correlations GM Rigolin, E Saccenti, C Bassi, L Lupini, FM Quaglia, M Cavallari, ... Journal of Hematology & Oncology 9, 1-9, 2016 | 56 | 2016 |
| In chronic lymphocytic leukaemia with complex karyotype, major structural abnormalities identify a subset of patients with inferior outcome and distinct biological characteristics GM Rigolin, E Saccenti, E Guardalben, M Cavallari, L Formigaro, ... British Journal of Haematology 181 (2), 229-233, 2018 | 47 | 2018 |
| Functional dosing of mesenchymal stromal cell-derived extracellular vesicles for the prevention of acute graft-versus-host-disease G Dal Collo, A Adamo, A Gatti, E Tamellini, R Bazzoni, P Takam Kamga, ... Stem Cells 38 (5), 698-711, 2020 | 44 | 2020 |
| Oncogenic mutations of MYD88 and CD79B in diffuse large B-cell lymphoma and implications for clinical practice C Visco, I Tanasi, FM Quaglia, I Ferrarini, C Fraenza, M Krampera Cancers 12 (10), 2913, 2020 | 41 | 2020 |
| Chronic lymphocytic leukemia management in Italy during the COVID-19 pandemic: a Campus CLL report A Cuneo, L Scarfò, G Reda, M Varettoni, FM Quaglia, M Marchetti, ... Blood, The Journal of the American Society of Hematology 136 (6), 763-766, 2020 | 39 | 2020 |
| Notch signaling molecules as prognostic biomarkers for acute myeloid leukemia P Takam Kamga, GD Collo, F Resci, R Bazzoni, A Mercuri, FM Quaglia, ... Cancers 11 (12), 1958, 2019 | 31 | 2019 |
| Response to ibrutinib of refractory life-threatening autoimmune hemolytic anemia occurring in a relapsed chronic lymphocytic leukemia patient with 17p deletion F Cavazzini, E Lista, FM Quaglia, L Formigaro, M Cavallari, S Martinelli, ... Leukemia & Lymphoma 57 (11), 2685-2688, 2016 | 25 | 2016 |
| Continous Treatment with Ibrutinib in 100 Untreated Patients with TP53 Disrupted Chronic Lymphocytic Leukemia. A Real-Life Campus CLL Study A Visentin, FR Mauro, F Cibien, C Vitale, G Reda, A Fresa, S Ciolli, ... American Journal of Hematology 97 (3), E95-E99, 2022 | 24 | 2022 |
| Fentanyl buccal tablet: a new breakthrough pain medication in early management of severe vaso‐occlusive crisis in sickle cell disease L De Franceschi, P Mura, V Schweiger, E Vencato, FM Quaglia, ... Pain Practice 16 (6), 680-687, 2016 | 20 | 2016 |
| Biological significance and prognostic/predictive impact of complex karyotype in chronic lymphocytic leukemia M Cavallari, F Cavazzini, A Bardi, E Volta, A Melandri, E Tammiso, ... Oncotarget 9 (76), 34398, 2018 | 19 | 2018 |
| An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and … GM Rigolin, L Formigaro, M Cavallari, FM Quaglia, E Lista, A Urso, ... Oncotarget 8 (17), 28008, 2017 | 18 | 2017 |
| Risk of hepatitis B virus reactivation in chronic lymphocytic leukemia patients receiving ibrutinib with or without antiviral prophylaxis. A retrospective multicentric GIMEMA study I Innocenti, G Reda, A Visentin, M Coscia, M Motta, R Murru, R Moia, ... Haematologica 107 (6), 1470, 2022 | 15 | 2022 |
| Long-term follow-up of rituximab plus bendamustine and cytarabine in older patients with newly diagnosed MCL MC Tisi, R Moia, C Patti, A Evangelista, S Ferrero, M Spina, M Tani, ... Blood Advances 7 (15), 3916-3924, 2023 | 13 | 2023 |
